I AM YOU is hosted by Dr. Nitza I. Alvarez, MD, FACC — board-certified cardiologist, Women’s Heart Specialist, and bestselling author. Each episode shares real stories and expert insights to help women protect the heart that carries them through every stage of life — and step into their power as the CEO of their own health.

In this episode, Dr. Alvarez confronts one of the most persistent fears surrounding menopause care: the belief that hormone therapy automatically causes breast cancer.

Many women experiencing sleeplessness, anxiety, weight gain, hot flashes, and other symptoms of hormonal transition are told to avoid estrogen and simply “push through” menopause. But reducing the hormone therapy conversation to breast cancer alone ignores the broader effects of declining estrogen on the brain, blood vessels, metabolism, inflammation, and cardiovascular system.

Dr. Alvarez explains how early interpretations of the Women’s Health Initiative created decades of fear and confusion—even though the women studied were, on average, over age 60 and more than 10 years past menopause. She discusses why the timing, type, and method of hormone therapy matter, and why treatment should never be approached as a universal yes-or-no decision.

With clarity and urgency, she breaks down:

• Why estrogen is more than a reproductive hormone—and how it helps regulate the brain, blood vessels, metabolism, and immune system
• How the timing of hormone therapy affects its risks and potential benefits
• The difference between estrogen-only therapy and combined estrogen-progestin therapy
• Why the breast cancer risk associated with combined therapy is often misunderstood or overstated
• The important difference between a family history and a personal history of breast cancer
• Why systemic hormone therapy is generally avoided in breast cancer survivors, but may require individualized discussion in severe cases
• When low-dose vaginal estrogen may still be considered with shared decision-making and oncology involvement
• How declining estrogen can contribute to arterial stiffness, inflammation, insulin resistance, changing cholesterol levels, and cardiovascular disease
• Why avoiding hormone therapy is not automatically the safest choice
• How women can evaluate their personal, metabolic, cardiovascular, and breast cancer risks more accurately

This episode challenges women to stop making healthcare decisions based solely on fear. Hormone therapy is not appropriate for every woman, but the decision must be based on personal history, cardiovascular risk, metabolic health, symptoms, timing, and the specific treatment being considered.

Hormone therapy is not the enemy. Misunderstanding it is.

Your symptoms are not random—they are signals of physiological change. Becoming the CEO of your own health means listening to those signals, asking informed questions, and seeking individualized care before silent changes develop into disease.

Visit NitzaMD.com
Follow @NitzaMD on Instagram and Facebook